Beta-adrenoceptor and cardiovascular effects of MJ 13105 (bucindolol) in anesthetized dogs and rats.
D000319:Adrenergic beta-Antagonists; D000758:Anesthesia; D000818:Animals; D002339:Carotid Arteries / Q000502:physiology; D002395:Catecholamines / Q000502:physiology; D004285:Dogs; D005260:Female; D006339:Heart Rate / Q000187:drug effects; D006439:Hemodynamics / Q000187:drug effects*; D006614:Hindlimb / Q000098:blood supply; D007211:Indoles / Q000494:pharmacology*; D008297:Male; D011412:Propanolamines / Q000494:pharmacology*; D051381:Rats; D012039:Regional Blood Flow / Q000187:drug effects; D012083:Renin / Q000097:blood; D013045:Species Specificity
D000319:Adrenergic beta-Antagonists; D002395:Catecholamines; D007211:Indoles; D011412:Propanolamines; C024307:bucindolol; D012083:Renin